Rutherford adds biomarker testing to improve the selection of best treatment for cancer patients
A partnership between Rutherford Health plc and OncoDNA, a genomic and theranostic company specialising in precision medicine, will provide Rutherford cancer patients with access to the latest biomarker testing. The partnership will support the accessibility and development of the tests in the UK. Comprehensive biomarker tests on solid and liquid biopsies help oncologists identify the […]
Read More